Status:
COMPLETED
The Effectiveness of the Modified Bundle in the Prevention of VAP.
Lead Sponsor:
Andrzej Frycz Modrzewski Krakow University
Conditions:
VAP - Ventilator Associated Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
Ventilator-associated pneumonia (VAP) is an important cause of prolonged intensive care unit and hospital length of stay, healthcare costs and mortality in mechanically ventilated patients. There are ...
Eligibility Criteria
Inclusion
- VAP2 - study group
- mechanically ventilated patients with an artificial airways (endotracheal tube, tracheostomy tube)
- age over 18 years
- modified bundle in the prevention of VAP
- VAP1 - historical group
- mechanically ventilated patients with an artificial airways (endotracheal tube, tracheostomy tube)
- patients hospitalised in the ICU for last 12 months before modified bundle in the prevention of VAP has been started (from 01.05.2017 to 30.04.2018)
- age over 18 years
- routine bundle in the prevention of VAP
Exclusion
- lack of an informed consent in awake patients in the ICU
- age under 18 years
- patients with no mechanical ventilation in the ICU
- patients with probability of mechanical ventilation days and LOS in the ICU less than 48 hours
- patients intubated and mechanically ventilated without the bundle in the prevention of VAP for a period of time longer than 12 hours before the admission to the ICU
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2019
Estimated Enrollment :
386 Patients enrolled
Trial Details
Trial ID
NCT04038814
Start Date
June 1 2018
End Date
July 15 2019
Last Update
July 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anaesthesiology and Intensive Care Unit St. Raphael Hospital
Krakow, Małopolska, Poland, 30-693